Biotechnology reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading. These reagents are used in the field of research, diagnosis, bioscience, and education. Biotechnology reagents & kits are essential tools for conducting experiments, analyzing biological samples, and creating biopharmaceuticals.
Market Dynamics:
Current RNA library preparation approaches are time-consuming, complex, and potentially error-prone, with sample loss observed at each stage in processes with multiple steps thus the key market players are engaged in launching new products and this is expected to propel growth of the global biotechnology reagents and kits market over the forecast period. For instance, in June 2022, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced the launch of the SEQuoia Express Stranded RNA Library Prep Kit. The kit provides biopharmaceutical and research scientists with an easy-to-use solution for constructing robust libraries to support efficient RNA-Seq workflows for comprehensive transcriptome profiling
Key features of the study:
- This report provides in-depth analysis of the global biotechnology reagents and kits market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global biotechnology reagents and kits market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., QIAGEN, New England Biolabs, Illumina, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, Takara Bio Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global biotechnology reagents and kits market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biotechnology reagents and kits market.
Detailed Segmentation:
- Global Biotechnology Reagents and Kits Market, By Kit Type:
- Purification Kits
- Amplification Kits
- Detection Kits
- Isolation Kits
- Others
- Global Biotechnology Reagents and Kits Market, By Technology:
- LAMP Technology
- PCR
- Cell Culture
- Sequencing
- Chromatography
- Electrophoresis
- Flow Cytometry
- Other Technologies
- Global Biotechnology Reagents and Kits Market, By Tested Parameters:
- DNA
- RNA
- Enzymes
- Proteins
- Others
- Global Biotechnology Reagents and Kits Market, By Micro-organisms:
- Bacteria
- Virus
- Fungi
- Parasites
- Global Biotechnology Reagents and Kits Market, By Purpose:
- Global Biotechnology Reagents and Kits Market, By End Use:
- Healthcare
- Food & Agriculture
- Natural Resources & Environment
- Industrial Processing
- Bioinformatics
- Global Biotechnology Reagents and Kits Market, By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Company Profiles:
- Thermo Fisher Scientific, Inc.
- QIAGEN
- New England Biolabs
- Illumina, Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche Ltd.
- Merck KGaA
- Promega Corporation
- Takara Bio Inc.
